Clinical Trial Update: To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating DE-104 ophthalmic solution for open-angle glaucoma or ocular hypertension has completed. The study was sponsored by Santen P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-104 ophthalmic solution (DE-104)

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED